Kraj: Nowa Zelandia
Język: angielski
Źródło: Medsafe (Medicines Safety Authority)
Hydrochlorothiazide 12.5mg; Losartan potassium 50mg
Boucher & Muir (New Zealand) Limited t/a BNM Group
Hydrochlorothiazide 12.5 mg
50mg/12.5mg
Film coated tablet
Active: Hydrochlorothiazide 12.5mg Losartan potassium 50mg Excipient: Hypromellose Lactose monohydrate Macrogol 4000 Magnesium stearate Microcrystalline cellulose Pregelatinised maize starch Purified talc Quinoline yellow Titanium dioxide
Blister pack, PVC/PVdC/Al, 98 tablets
Prescription
Prescription
Cambrex Profarmaco Milano Srl
Losartan HCTad is indicated for the treatment of hypertension, for patients in whom combination therapy is appropriate.
Package - Contents - Shelf Life: Blister pack, PVC/PVdC/Al - 90 tablets - 60 months from date of manufacture stored at or below 30°C protect from moisture - Blister pack, PVC/PVdC/Al - 98 tablets - 60 months from date of manufacture stored at or below 30°C protect from moisture
2011-05-24
1 LOSARTAN HCTAD 50MG/12.5MG 22092011 New Zealand Consumer Medicine Information LOSARTAN HCTAD ® 50MG/12.5MG _LOSARTAN POTASSIUM/HYDROCHLOROTHIAZIDE _ _ _ 50 mg/12.5 mg Film-coated tablets WHAT IS IN THIS LEAFLET Please read this leaflet carefully before you start taking Losartan HCTad. This leaflet answers some common questions about Losartan HCTad. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you taking Losartan HCTad against the benefits this medicine is expected to have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING LOSARTAN HCTAD, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may want to read it again. WHAT LOSARTAN HCTAD IS USED FOR Losartan HCTad lowers high blood pressure, which doctors call hypertension. It may be used alone or in combination with other medicines. In patients with high blood pressure and a thickening of the left ventricle, losartan, often in combination with hydrochlorothiazide, reduces the risk of stroke and heart attack and helps patients live longer. Everyone has blood pressure. This pressure helps get your blood all around your body. Your blood pressure may be different at different times of the day, depending on how busy or worried you are. You have hypertension (high blood pressure) when your blood pressure stays higher than is needed, even when you are calm and relaxed. Over time, high blood pressure causes the heart to work harder, which can lead to a thickening of the left ventricle. A thickening of the left ventricle of the heart is associated with an increased chance of experiencing a stroke. There are Przeczytaj cały dokument
1 LOSARTAN HCTAD 50MG/12.5MG 22092011 NEW ZEALAND DATA SHEET LOSARTAN HCTAD ® 50MG/12.5MG LOSARTAN POTASSIUM/HYDROCHLOROTHIAZIDE FILM-COATED TABLETS, 50 MG/12.5 MG PRESENTATION One Losartan HCTad tablet contains losartan potassium 50 and hydrochlorothiazide (HCT) 12.5 mg. Losartan HCTad tablets are yellow, oval, slightly biconvex, film-coated tablets. Diameter: 6 mm x 12 mm (oval). Thickness: 3.8 mm – 4.7 mm. INDICATIONS HYPERTENSION Losartan HCTad is indicated for the treatment of hypertension, for patients in whom combination therapy is appropriate. REDUCTION IN THE RISK OF CARDIOVASCULAR MORBIDITY AND MORTALITY IN HYPERTENSIVE PATIENTS WITH LEFT VENTRICULAR HYPERTROPHY Losartan HCTad is a combination of losartan and hydrochlorothiazide. In patients with hypertension and left ventricular hypertrophy, losartan, often in combination with hydrochlorothiazide, reduces the risk of cardiovascular morbidity and mortality as measured by the combined incidence of cardiovascular death, stroke, and myocardial infarction in hypertensive patients with left ventricular hypertrophy (see Warnings and Precautions, Ethnic differences). DOSAGE AND ADMINISTRATION Losartan HCTad may be administered with other antihypertensive agents. Losartan HCTad may be administered with or without food. HYPERTENSION The usual starting and maintenance dose of Losartan HCTad (losartan 50 mg/HCT 12.5 mg) is one tablet once daily. For patients who do not respond adequately to Losartan HCTad, the dosage may be increased to two tablets once daily. The maximum dose is two tablets once daily. In general the antihypertensive effect is attained within three weeks after initiation of therapy. 2 LOSARTAN HCTAD 50MG/12.5MG 22092011 Losartan HCTad should not be initiated in pati Przeczytaj cały dokument